BART MILNER: Open Payments
NPI 1811222706 · EASTMAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 11 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $75 |
| Astellas Pharma US Inc | 4 | $61 |
| Organogenesis Inc. | 1 | $50 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Veozah, MOUNJARO, APLIGRAF, GEMTESA, ZEPBOUND, INGREZZA.
Industry payments across GA — which companies pay providers there.
